Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for DXCM, sign up here.
Income Statement
Revenue
$3.6bn
Gross Profit
$2.3bn
Earning before Tax
$710.4m
Net Income
$541.5m
Net Income Common Shareholders
$541.5m
EPS
1.40
Balance Sheet
Cash
$566.3m
Debt
$2.5bn
Assets
$6.3bn
Liabilities
$4.2bn
Equity
$2.1bn
Enterprise Value
$50.0bn
Cash Flow Statement
Net Cash from Operations
$748.5m
Net Cash from Investing
$-0.5bn
Net Cash from Financing
$-0.3bn
Net Cash Flow
$-75.8m
Free Cash Flow
$511.9m
Free Cash Flow per Share
$1.33
Metrics
Price to Equity
88.54
Price to Equity (Damodaran)
88.64
Price to Book
23.18
Net Margin
0.15
Return on Equity
0.25
Return on Sales
0.20
Get immediate access to 5-years of reference grade data for DXCM for free.
Sign upDexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Company Info
Industry
Medical Devices
Employees
7,500
Address
6340 Sequence Drive
San Diego, CA 92121
United States
Phone
858 200 0200
Website
Last Updated
2024-02-08
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.